Batm Advanced Communicat... Share Discussion Threads

[wizzkid211] 12/3/2024 07:10

gross margin up to 47.1% networking div.

[wizzkid211] 12/3/2024 07:07

Commenting on the results, Moti Nagar, Chief Executive Officer of BATM, said:



"I am proud of what we achieved in 2023. Against a challenging macroeconomic backdrop, we delivered growth in sales and adjusted EBITDA - including an outstanding performance in our Cyber business. We launched several innovative new products in Diagnostics and Networking that have been well-received, whilst progressing development of potentially game-changing solutions. Significantly, we undertook an in-depth strategic review that resulted in the establishment of a new strategy, which we began to implement in the second half of the year. Our new strategy is focused on accelerating our activities that build on our established areas of core expertise and which are in scalable and growing markets. This involves enhancing how we operate as a business, prioritising resource allocation and potential M&A activity. We have already taken important steps forward in this process and I am excited about the progress we will make in 2024. Accordingly, and supported by our strong balance sheet, we look to the future with confidence and look forward to reporting on our progress."

[wizzkid211] 12/3/2024 07:02

Financial Highlights

$m

2023

2022

Revenue

122.8

116.1

Gross profit

39.9

38.0

Gross margin

32.5%

32.7%

Adj. operating profit*

5.0

4.0

Adj. EBITDA*

9.3

8.3

Adj. profit before tax*

4.8

2.8

Net cash from (used in) operating activities

5.0

(2.8)

[paulisi] 11/3/2024 09:47

I'm hoping, as we have a closed period, that as well as the accounts, we have some contract announcements.

[kooba] 08/3/2024 10:24

all good and reasonable questions…i have tabled one around ADOR ..which might be over egged! ButI think shareholders should be putting all of those up..the other thing is progress on implementing the strategic review , now i know that the situation following the horrific attack on innocent people has likely impacted the company slightly more than they initially said but its still a fair and reasonable point on progress in trying to refocus the business on the core areas they reported to shareholders. Hopefully i will be able to listen to the webcast.

[resistance1] 08/3/2024 08:38

I think there are quite a few potential questions that we need clarity on:

1. Ador time-line is it 12 months? Reference the 2019 timeline at cash injection.
2. Time-line for commercial Cyber product. Last Summer it was this summer ‘24. On track?
3. Edgility. With the investment in sales teams how long are you giving to see measurable success before other options (disposal/JV’s) are considered?

[kooba] 07/3/2024 17:29

Interesting to recap on the IC comment after the interims…much promised…little news though.

[kooba] 07/3/2024 17:19

There is still a lot of corporate activity in cyber going on …big numbers but most are targeting commercial markets not relying on a single state customer.
If their stuff is good they need to get into commercial markets to achieve value and potential exit or listing. They need to get a shift on.

[paulisi] 07/3/2024 11:26

Zoom link now received for next week.Questions submitted.

[kooba] 06/3/2024 12:54

Thats all very well but to know the value of the tech you need to know the competitive market offerings which seem to have become a more crowded space as ADOR has sat on their hands. I’ve seen mention OxFORD NANOPORE a globally recognised and well funded player and if you scratch the surface many other companies are working on molecular diagnostic products at various levels and believing the company’s hype with no sales demonstrating the attractiveness of their product ( to be) is taking a fair bit on trust. Companies like ONT already have large global sales in genetics and a reputation for leading edge technologies..that is some head start.
Once again BATM have been early finding a solution to a problem and are slow to market and even slower to be able to sell as the industry catches up and often overtakes their efforts. Hopefully this still has potential as a low priced localised or mobile diagnostic device..but the market wont wait for them to get their act together.

[resistance1] 06/3/2024 09:01

Agreed a progress report on ADOR is much needed. I’m not too concerned about the weakened book value, as this investment is focussed on delivering a market ready product (but later than forecast with apparent cost over-runs.) In the capital markets day blurb NatLab will be a head and shoulders above the competition in terms of speed of diagnosis time and comparative panel (diagnosis) cost. For hard pressed health providers this the key factor. Deliver a working solution post clinical trials and a major diagnostics player will pay x10 on the investment made.

[kooba] 05/3/2024 19:09

I look forward to some honest updates on ADOR too.

[kooba] 05/3/2024 19:07

Moti in Oct 2023 when Batm put more money in on a massively down round..does this sound like a company whose value appears to have cratered??

Moti Nagar, CEO of BATM, said: “We are very excited about the groundbreaking potential of ADOR, which has a technology that is set to truly disrupt the molecular diagnostics market – and is backed by a strong and growing international patent portfolio. This investment, supported by our vast experience of transforming IP into market-ready products, will advance the development of ADOR towards what we believe will be a significant value creation opportunity for BATM. We look forward to reporting on ADOR’s progress.”

[kooba] 05/3/2024 18:56

I think it would be good if the company was transparent on such important holdings where they have committed significant capital. If my numbers are correct it’s very significant in terms of value especially against market capitalisation and should be addressed…they could say they gave the numbers and shareholders could have worked it out ..I think that is not honest and they should have been open if the company faltered and it was a rescue funding at little pre new money value. The shareholders own the company and deserve to be fully informed on material assets and their performance…..there is virtually no information available on ADOR so we are reliant on the company keeping us informed of its progress. I have asked the question on valuation..see if they address it in the meeting.

[fse] 05/3/2024 14:23

Re. Mobile world congress Barcelona where edgility are exhibiting and mentioned. Again !

Unlike the vendors above, Edgility from Telco Systems focuses on the on-premises edge – IoT networks that have the luxury of gateways that can run in near-edge environments like server rooms, telco points-of-presence, or even data centers.

Edgility provides a Linux-based operating system that runs on any hardware platform, including IoT gateways with Raspberry Pi-level capabilities. In addition, the Edgility software manages and orchestrates each of the Edgility-powered boxes across distributed, global edge deployments far more efficiently than traditional approaches.

These boxes can run business applications as well as virtual routing and firewall capabilities, dramatically reducing the number of boxes that customers require to support complex IoT deployments.

They are also in. Las Vegas



Clip at the bottom of that page

"Edgility enables us to efficiently manage vast numbers of physical edge devices which is critical, as our network rollout continues to scale.
CityFiber
David Tomalin, Group CTO, CityFibre"

[resistance1] 05/3/2024 08:59

For whatever reason (covid, leadership or both) Ador seemed to lose its way between the start of 2019 and till the appointment of the Eran Zahavy as Ador CEO in mid 2022. It seems now the development is being properly driven towards certification, post clinical trials approx 1-year from now. At which point it should be sold or a JV set up with a big player similar to what Oxford Nanopore have done with bioMérieux

[kooba] 04/3/2024 17:30

I’m not sure how they apply a book value but if this was a listed investment fund and valuations were taken from last fundraise there could be a large write down in the book value of the holding…it might also question the strategy of investing into separate vehicles they don’t control ..though they do have a director on the ADOR board , the Chairman a Dr Zvi Marom.

[echoridge] 04/3/2024 11:31

that 500k was included in the Stifel total I mentioned, wilske

[wilske] 04/3/2024 10:30

Just to add another 500k trade went through right at the last minute before 18.00 on Friday evening. Very strange. I would expect a couple of TR-1 RNSs tomorrow

[gbenson1] 04/3/2024 07:56

If the 10+m trade from Friday is kosher then it's 2.3 ish % of the company so a RNS must be due!!

[echoridge] 02/3/2024 18:57

Yeah, maybe, fse. Will check Monday when if the main part of that, the 10.4m share bargain, was legit in the sense of a real seller/real buyer. It’s possible, but for now, I’m skeptical.

[fse] 01/3/2024 18:08

Well another 12M squirrelled away somewhere ahead of results.